Developing Progenitor T-Cell Therapy to Maintain Effective & Diverse TCRs while Ensuring Safety
Time: 11:30 am
day: Day One - Track A AM
Details:
- Producing T-cell progenitors (ProTcell) with a feeder cell-free manufacturing process designed to generate clinical batches
- Infusing ProTcells that get educated and develop in the host thymus to participate in immune response without generating GvHD
- Characterizing ProTcells and T-cells generated after further maturation in artificial thymic organoids or in vivo
